logo
  

Power Integrations Results Top Estimates

Semiconductor company Power Integrations (POWI) on Wednesday reported fourth-quarter net earnings of $14.4 million or $0.48 per share compared with $16.1 million or $0.52 per share last year.

Excluding items, adjusted earnings for the quarter were $0.59 per share compared with $0.66 per share a year ago.

Revenues for the quarter were $86.6 million compared with $90.4 million in the prior year.

Analysts polled by Thomson Reuters estimated earnings of $0.52 per share on revenues of $86 million for the quarter. Analysts' estimates typically exclude special items.

The company's gross margin for the quarter fell to 52.9% from 53.5% a year ago, and operating margin slid to 13.7% from 16.7%.

For the first quarter, the company expects revenues of $82 million to $88 million, while analysts expect $85.8 million.

The company's CEO Balu Balakrishnan said, "While disappointed with our 2014 results overall, we closed out the year with a solid quarter and now look forward to renewed growth in 2015."

"We are embarking on a promising new product cycle led by the revolutionary InnoSwitch family... At the same time, secular trends such as energy efficiency, renewable energy and faster charging of mobile devices continue to drive adoption of our highly integrated power-conversion products," Balakrishnan said.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Lincoln Park, New Jersey -based ConSup North America Inc. is recalling around 85,984 pounds of ready-to-eat or RTE sliced prosciutto ham product produced in Germany without the benefit of equivalent inspection, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and...

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
RELATED NEWS
Follow RTT